✦ LIBER ✦

Glucagon-like peptide-1-based therapies: new developments and emerging data

✍ Scribed by Alan J. Garber

Book ID: 109044693
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 176 KB
Volume: 10
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2008.00921.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Emerging incretin (glucagon-like peptide

Emerging incretin (glucagon-like peptide-1)-derived therapies for type 2 diabetes

✍ Alan J. Garber 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB

Glucagon-like peptide-1-based therapies

Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control

✍ P. Anagnostis; V. G. Athyros; F. Adamidou; A. Panagiotou; M. Kita; A. Karagianni 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

Glucagon-like peptide 1 based therapy fo

Glucagon-like peptide 1 based therapy for type 2 diabetes

✍ Bao-Sheng Yu; An-Ru Wang 📂 Article 📅 2008 🏛 SP Children’s Hospital, Zhejiang University School 🌐 English ⚖ 116 KB

Synthesis and characterization of ester-

Synthesis and characterization of ester-based prodrugs of glucagon-like peptide 1

✍ Arnab De; Richard D. DiMarchi 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 603 KB

## Abstract Peptides represent a rich natural source of potential medicines with one notable pharmaceutical limitation being their relatively short duration of action. A particularly good example of this phenomenon is glucagon‐like peptide 1 (GLP), a hormone of appreciable interest for the treatmen

Therapy of type 2 diabetes mellitus base

Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1

✍ Jens Juul Holst 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Glucagon-like peptide-1 therapy and the

Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?

✍ P. C. Butler; A. V. Matveyenko; S. Dry; A. Bhushan; R. Elashoff 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 154 KB